RU2014126297A - METHOD FOR ASSESSING TUBERCULEMA ACTIVITY - Google Patents

METHOD FOR ASSESSING TUBERCULEMA ACTIVITY Download PDF

Info

Publication number
RU2014126297A
RU2014126297A RU2014126297A RU2014126297A RU2014126297A RU 2014126297 A RU2014126297 A RU 2014126297A RU 2014126297 A RU2014126297 A RU 2014126297A RU 2014126297 A RU2014126297 A RU 2014126297A RU 2014126297 A RU2014126297 A RU 2014126297A
Authority
RU
Russia
Prior art keywords
activity
tuberculema
assessing
tuberculoma
leukocytes
Prior art date
Application number
RU2014126297A
Other languages
Russian (ru)
Other versions
RU2585385C2 (en
Inventor
Ольга Викторовна Бердюгина
Анастасия Викторовна Ершова
Антон Викторович Неретин
Original Assignee
Ольга Викторовна Бердюгина
Анастасия Викторовна Ершова
Антон Викторович Неретин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ольга Викторовна Бердюгина, Анастасия Викторовна Ершова, Антон Викторович Неретин filed Critical Ольга Викторовна Бердюгина
Priority to RU2014126297/15A priority Critical patent/RU2585385C2/en
Publication of RU2014126297A publication Critical patent/RU2014126297A/en
Application granted granted Critical
Publication of RU2585385C2 publication Critical patent/RU2585385C2/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Способ оценки активности туберкулемы, включающий исследование крови, отличающийся тем, что в цельной крови определяют количество CD 19+клеток в процентном содержании от числа всех лейкоцитов методом проточной цитофлюориметрии и при их количестве менее 9% оценивают ее как активную, а при величине равной или более 9% оценивают ее как неактивную.A method for evaluating the activity of tuberculoma, including a blood test, characterized in that in whole blood the number of CD 19 + cells is determined as a percentage of the number of all leukocytes by flow cytofluorimetry, and when their number is less than 9%, it is evaluated as active, and when the value is equal to or more 9% rate it as inactive.

Claims (1)

Способ оценки активности туберкулемы, включающий исследование крови, отличающийся тем, что в цельной крови определяют количество CD 19+клеток в процентном содержании от числа всех лейкоцитов методом проточной цитофлюориметрии и при их количестве менее 9% оценивают ее как активную, а при величине равной или более 9% оценивают ее как неактивную. A method for evaluating the activity of tuberculoma, including a blood test, characterized in that in whole blood the number of CD 19 + cells is determined as a percentage of the number of all leukocytes by flow cytofluorimetry, and when their number is less than 9%, it is evaluated as active, and when the value is equal to or more 9% rate it as inactive.
RU2014126297/15A 2014-06-27 2014-06-27 Method for assessing tuberculoma activity RU2585385C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014126297/15A RU2585385C2 (en) 2014-06-27 2014-06-27 Method for assessing tuberculoma activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014126297/15A RU2585385C2 (en) 2014-06-27 2014-06-27 Method for assessing tuberculoma activity

Publications (2)

Publication Number Publication Date
RU2014126297A true RU2014126297A (en) 2016-01-27
RU2585385C2 RU2585385C2 (en) 2016-05-27

Family

ID=55237128

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014126297/15A RU2585385C2 (en) 2014-06-27 2014-06-27 Method for assessing tuberculoma activity

Country Status (1)

Country Link
RU (1) RU2585385C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2400149C1 (en) * 2009-06-15 2010-09-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Differential diagnostic technique of round pulmonary shadows in patients with chronic obstructive pulmonary disease
RU2405151C2 (en) * 2009-07-13 2010-11-27 Наталия Васильевна Ставицкая Method for evaluation of risk of progressing latent tuberculous infection in children
UA64465U (en) * 2011-04-07 2011-11-10 Харьковская Медицинская Академия Последипломного Образования Method for diagnostics of dysplasia of connective tissue in patients with tuberculosis of respiratory system
RU2480765C1 (en) * 2011-12-07 2013-04-27 Федеральное государственное бюджетное учреждение "Центральный научно-исследовательский институт туберкулеза" Российской академии медицинских наук Method of estimating clinical effectiveness in pulmonary tuberculosis

Also Published As

Publication number Publication date
RU2585385C2 (en) 2016-05-27

Similar Documents

Publication Publication Date Title
CY1123142T1 (en) IMPROVED METHODS FOR THE PRODUCTION OF POSITIVE CELL THERAPEUTICS
EA201790357A1 (en) METHOD FOR GETTING PRECEDENTIAL CELLS OF THE Mature Liver
EA201790377A1 (en) ANTIBODIES TO GLUCAGON AND THEIR APPLICATIONS
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
EA201791775A1 (en) CYTESTINE PROTEASIS
MX2021010528A (en) Methods and compositions for treating ulcers.
EA201790195A1 (en) METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS
MA52909A (en) METHODS FOR INCREASING RED BLOOD CELLS AND SICKLE CELL TREATMENT
EA201591754A1 (en) HUMAN ANTIBODIES TO NA1.7
EA201591743A8 (en) STIMULATORS sGC
MX2016009060A (en) Methods and systems for determining risk of heart failure.
EA201500852A1 (en) The forms of methyl {4,6-diamine-2- [1- (2-fluoro-benzyl) -1H-pyrazolo [3,4-b] pyridine-3-il] pyrimidino-5-il} methyl methyl carbamide
EA201492184A1 (en) METHODS OF TREATMENT OF METABOLIC SYNDROME BY MODULATING PROTEIN HEAT SHOCK (HSP) 90-BETA
EA201790769A1 (en) DETERMINATION OF THE LEVELS OF GLYCOSAMINOGLICANES BY THE MASS SPECTROMETRY METHOD
BR112016025511A2 (en) techniques for serialized execution in simd processing system
BR102012002812A8 (en) method to determine the influence of a variable on a phenomenon
EA201490638A1 (en) COMPOSITIONS AND METHODS OF TREATING CANCER WITH THE USE OF PI3Kβ INHIBITOR AND MAPK SIGNAL PATH INHIBITOR, INCLUDING MEK AND RAF INHIBITORS
AR104805A1 (en) METHODS AND COMPOSITIONS TO EVALUATE CANCER RESPONSE RESPONSE TO BET INHIBITORS
MX2017006491A (en) Compositions and methods for modulating at2r activity.
RU2014126297A (en) METHOD FOR ASSESSING TUBERCULEMA ACTIVITY
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
RU2012131963A (en) METHOD FOR DETERMINING THE TOTAL ALLOWABLE FISH CATCH
RU2014110649A (en) METHOD FOR DIAGNOSTIC OF STENT STENOSING DEVELOPMENT
MX2017011467A (en) Pd-ecgf as biomarker of cancer.
RU2014144153A (en) A method for determining the severity of genomic stability (instability), genetic variability in groups, fish populations and their individual individuals

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160628